Getting your Trinity Audio player ready... A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions ...

LONDON (Reuters) - A copy of the blockbuster biotech drug Enbrel was recommended for approval in Europe on Friday, making it the second so-called biosimilar antibody medicine to win such a green light ...

WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...

A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

Amgen said Friday it applied for clearance to begin using a manufacturing plant in Rhode Island to make rheumatoid arthritis treatment Enbrel. There has been a continuing problem with insufficient ...

LONDON, Nov 20 (Reuters) - A copy of the blockbuster biotech drug Enbrel was recommended for approval in Europe on Friday, making it the second so-called biosimilar antibody medicine to win such a ...

A drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw out the state board that deemed its medication unaffordable. In February, the Colorado Prescription ...

The competing rheumatoid arthritis drugs of Immunex Corp. and Johnson & Johnson may offer effective new approaches to easing the chronic skin flares of psoriasis, new research shows. A study presented ...

The U.S. government this week released the list of the 10 medications that will be the first to be the subject of the new price negotiations under the Medicare reform bill, and my arthritis drug, ...

Susan Estrich is the Robert Kingsley Professor of Law and Political Science at the University of Southern California Law Center as well as being a syndicated columnist. The U.S. government this week ...

Amgen Inc. on Tuesday reported fourth-quarter profits and sales that topped analysts’ expectations even as revenues dropped for one of its top sellers, the rheumatoid-arthritis drug Enbrel. The ...